Operational feasibility and reproducibility of serial echocardiographic parameters of left ventricular remodelling and function for evaluation of drug efficacy in multicentre clinical trial settings
13 December 2024 (09:30 - 10:15)
Organised by: 

Abstract
Slides
About the speaker

AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)
3 More presentations in this session
Doctor A. Szyszkowska (Bialystok, PL)
Doctor L. Bianchi (Maastricht, NL)
Access the full session
The Event
EuroEcho-Imaging 2024
13 December 2024
09:30 CET
